My question is for Mr. Blouin, from Merck Frosst Canada.
I listened carefully to your presentation, and I have looked at your document. You are making us aware of the importance of vaccination; I think that is a good thing. You mentioned a vaccine called ZOSTAVAX, which is excluded from the NIS, despite the fact that it has received approval from the National Advisory Committee on Immunization.